Wellinks is a dynamic and innovative COPD-focused digital health company fueled by a mission to empower people in their pursuit to breathe freely. Wellinks’ lead asset is a digitally enabled and outcomes-driven holistic COPD treatment with a focus on reinventing respiratory care.
The company’s expertise in COPD innovation began with the development and FDA 510(k) clearance of Flyp Nebulizer, the first truly pocket-portable nebulizer, allowing patients simple, convenient, and connected access to breathing treatments.